Skip to main content

Seaport Therapeutics, Inc.

SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002042347

No open-market purchases or sales by Seaport Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $815.3M in total; no superinvestor holds it.

Members of Congress who traded SPTX

No member of Congress has reported a trade in Seaport Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.